BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16759374)

  • 1. Cdk2 and Cdk4 cooperatively control the expression of Cdc2.
    Berthet C; Kaldis P
    Cell Div; 2006 Jun; 1():10. PubMed ID: 16759374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined loss of Cdk2 and Cdk4 results in embryonic lethality and Rb hypophosphorylation.
    Berthet C; Klarmann KD; Hilton MB; Suh HC; Keller JR; Kiyokawa H; Kaldis P
    Dev Cell; 2006 May; 10(5):563-73. PubMed ID: 16678773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of p27-CDK complexes during the human mitotic cell cycle.
    Soos TJ; Kiyokawa H; Yan JS; Rubin MS; Giordano A; DeBlasio A; Bottega S; Wong B; Mendelsohn J; Koff A
    Cell Growth Differ; 1996 Feb; 7(2):135-46. PubMed ID: 8822197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.
    Jaumot M; Estanyol JM; Serratosa J; Agell N; Bachs O
    Hepatology; 1999 Feb; 29(2):385-95. PubMed ID: 9918914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cdk1 is sufficient to drive the mammalian cell cycle.
    Santamaría D; Barrière C; Cerqueira A; Hunt S; Tardy C; Newton K; Cáceres JF; Dubus P; Malumbres M; Barbacid M
    Nature; 2007 Aug; 448(7155):811-5. PubMed ID: 17700700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E1A can provoke G1 exit that is refractory to p21 and independent of activating cdk2.
    Akli S; Zhan S; Abdellatif M; Schneider MD
    Circ Res; 1999 Aug; 85(4):319-28. PubMed ID: 10455060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells.
    Sweeney KJ; Sarcevic B; Sutherland RL; Musgrove EA
    Oncogene; 1997 Mar; 14(11):1329-40. PubMed ID: 9178893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cdk1, but not Cdk2, is the sole Cdk that is essential and sufficient to drive resumption of meiosis in mouse oocytes.
    Adhikari D; Zheng W; Shen Y; Gorre N; Ning Y; Halet G; Kaldis P; Liu K
    Hum Mol Genet; 2012 Jun; 21(11):2476-84. PubMed ID: 22367880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDK2 and CDK4: Cell Cycle Functions Evolve Distinct, Catalysis-Competent Conformations, Offering Drug Targets.
    Zhang W; Liu Y; Jang H; Nussinov R
    JACS Au; 2024 May; 4(5):1911-1927. PubMed ID: 38818077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal Models for Studying the In Vivo Functions of Cell Cycle CDKs.
    Risal S; Adhikari D; Liu K
    Methods Mol Biol; 2016; 1336():155-66. PubMed ID: 26231715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2.
    Kitagawa M; Higashi H; Jung HK; Suzuki-Takahashi I; Ikeda M; Tamai K; Kato J; Segawa K; Yoshida E; Nishimura S; Taya Y
    EMBO J; 1996 Dec; 15(24):7060-9. PubMed ID: 9003781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal patterns of gene expression of G1-S cyclins and cdks during the first and second mitotic cell cycles in mouse embryos.
    Moore GD; Ayabe T; Kopf GS; Schultz RM
    Mol Reprod Dev; 1996 Nov; 45(3):264-75. PubMed ID: 8916036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caco-2 intestinal cell differentiation is associated with G1 arrest and suppression of CDK2 and CDK4.
    Ding QM; Ko TC; Evers BM
    Am J Physiol; 1998 Nov; 275(5):C1193-200. PubMed ID: 9814966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Slower CDK4 and faster CDK2 activation in the cell cycle.
    Zhang W; Liu Y; Jang H; Nussinov R
    Structure; 2024 Apr; ():. PubMed ID: 38703777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical characterizations reveal different properties between CDK4/cyclin D1 and CDK2/cyclin A.
    Kim DM; Yang K; Yang BS
    Exp Mol Med; 2003 Oct; 35(5):421-30. PubMed ID: 14646596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle progression mechanisms: slower cyclin-D/CDK4 activation and faster cyclin-E/CDK2.
    Zhang W; Liu Y; Jang H; Nussinov R
    bioRxiv; 2023 Aug; ():. PubMed ID: 37790340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoiesis specific loss of Cdk2 and Cdk4 results in increased erythrocyte size and delayed platelet recovery following stress.
    Jayapal SR; Wang CQ; Bisteau X; Caldez MJ; Lim S; Tergaonkar V; Osato M; Kaldis P
    Haematologica; 2015 Apr; 100(4):431-8. PubMed ID: 25616574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDK2 regulation through PI3K and CDK4 is necessary for cell cycle progression of primary rat hepatocytes.
    Wierød L; Rosseland CM; Lindeman B; Oksvold MP; Grøsvik H; Skarpen E; Huitfeldt HS
    Cell Prolif; 2007 Aug; 40(4):475-87. PubMed ID: 17635516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of G1 cyclin-dependent kinase activity during growth arrest of human astrocytoma cells by the pyrrolo-1,5-benzoxazepine, PBOX-21.
    Mulligan JM; Campiani G; Ramunno A; Nacci V; Zisterer DM
    Biochim Biophys Acta; 2003 Sep; 1639(1):43-52. PubMed ID: 12943967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.